• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

向非小细胞肺癌细胞中添加神经降压素会增加 HER3 的酪氨酸磷酸化。

Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.

机构信息

Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Center for Cancer Training, Bethesda, MD 20892, USA.

National Institute of Diabetes, Digestive and Kidney Disease, Digestive Diseases Branch, 9000 Rockville Pike, Bethesda, MD 20892 USA.

出版信息

Peptides. 2022 Oct;156:170858. doi: 10.1016/j.peptides.2022.170858. Epub 2022 Aug 3.

DOI:10.1016/j.peptides.2022.170858
PMID:35932909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9529830/
Abstract

Neurotensin (NTS) receptor 1 regulates the growth non-small cell lung cancer (NSCLC) cells. NTS binds with high affinity to NTSR1, leading to increased tyrosine phosphorylation of the EGFR and HER2. Using Calu3, NCI-H358, or NCI-H441 cells, the effects of NTS on HER3 transactivation were investigated. HER3 tyrosine phosphorylation was increased by NTS or neuregulin (NRG1) addition to NSCLC cells. NCI-H358, NCI-H441, and Calu-3 cells have HER3, NTSR1 and neuregulin (NRG)1 protein. NTSR1 regulation of HER3 transactivation was impaired by SR48692 (NTSR1 antagonist) or monoclonal antibody (mAb)3481 (HER3 blocker). Immunoprecipitation experiments indicated that NTS addition to NCI-H441cells resulted in the formation of EGFR/HER3 and HER2/HER3 heterodimers. The ability of NTS to increase HER3 tyrosine phosphorylation was impaired by GM6001 (MMP inhibitor), PP2 (Src inhibitor), Tiron (superoxide scavenger), or N-acetylcysteine (antioxidant). Adding NTS to NSCLC cells increased phosphorylation of ERK, HER3, and AKT. NTS or NRG1 increased colony formation of NSCLC cells which was strongly inhibited by SR48692 and mAb3481. The results indicate that NTSR1 regulates HER3 transactivation in NSCLC cells leading to increased proliferation.

摘要

神经降压素(NTS)受体 1 调节非小细胞肺癌(NSCLC)细胞的生长。NTS 与 NTSR1 具有高亲和力结合,导致 EGFR 和 HER2 的酪氨酸磷酸化增加。使用 Calu3、NCI-H358 或 NCI-H441 细胞,研究了 NTS 对 HER3 转激活的影响。NTS 或神经调节蛋白(NRG1)的添加增加了 NSCLC 细胞中 HER3 的酪氨酸磷酸化。NCI-H358、NCI-H441 和 Calu-3 细胞具有 HER3、NTSR1 和神经调节蛋白(NRG)1 蛋白。NTSR1 对 HER3 转激活的调节被 SR48692(NTSR1 拮抗剂)或单克隆抗体(mAb)3481(HER3 阻滞剂)所损害。免疫沉淀实验表明,NTS 的添加导致 NCI-H441 细胞中 EGFR/HER3 和 HER2/HER3 异二聚体的形成。GM6001(基质金属蛋白酶抑制剂)、PP2(Src 抑制剂)、Tiron(超氧化物清除剂)或 N-乙酰半胱氨酸(抗氧化剂)可削弱 NTS 增加 HER3 酪氨酸磷酸化的能力。向 NSCLC 细胞中添加 NTS 增加了 ERK、HER3 和 AKT 的磷酸化。NTS 或 NRG1 增加了 NSCLC 细胞的集落形成,这一作用被 SR48692 和 mAb3481 强烈抑制。结果表明,NTSR1 调节 NSCLC 细胞中 HER3 的转激活,导致增殖增加。

相似文献

1
Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.向非小细胞肺癌细胞中添加神经降压素会增加 HER3 的酪氨酸磷酸化。
Peptides. 2022 Oct;156:170858. doi: 10.1016/j.peptides.2022.170858. Epub 2022 Aug 3.
2
SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.SR48692 通过依赖于表皮生长因子受体的方式抑制非小细胞肺癌增殖。
Life Sci. 2014 Mar 28;100(1):25-34. doi: 10.1016/j.lfs.2014.01.072. Epub 2014 Feb 2.
3
Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.神经降压素(NTS)及其受体(NTSR1)可导致肺肿瘤中表皮生长因子受体(EGFR)、人表皮生长因子受体2(HER2)和人表皮生长因子受体3(HER3)的过表达及其自分泌/旁分泌激活,证实了对厄洛替尼的反应性。
Oncotarget. 2014 Sep 30;5(18):8252-69. doi: 10.18632/oncotarget.1633.
4
The G Protein-Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3.G 蛋白偶联受体 PAC1 调节受体酪氨酸激酶 HER3 的转激活。
J Mol Neurosci. 2021 Aug;71(8):1589-1597. doi: 10.1007/s12031-020-01711-8. Epub 2020 Sep 22.
5
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.神经降压素/神经降压素受体1对表皮生长因子受体(EGFR)、人表皮生长因子受体2(HER2)和人表皮生长因子受体3(HER3)的激活作用,使乳腺肿瘤具有侵袭性,但在小鼠中对拉帕替尼和二甲双胍高度敏感。
Oncotarget. 2014 Sep 30;5(18):8235-51. doi: 10.18632/oncotarget.1632.
6
Neurotensin receptors regulate transactivation of the EGFR and HER2 in a reactive oxygen species-dependent manner.神经降压素受体通过依赖活性氧的方式调节 EGFR 和 HER2 的转激活。
Eur J Pharmacol. 2019 Dec 15;865:172735. doi: 10.1016/j.ejphar.2019.172735. Epub 2019 Oct 12.
7
Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer.癌症中的肽类G蛋白偶联受体与表皮生长因子受体酪氨酸激酶
Biology (Basel). 2023 Jul 4;12(7):957. doi: 10.3390/biology12070957.
8
CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.CI-988抑制因向肺癌细胞添加胆囊收缩素/胃泌素而导致的表皮生长因子受体(EGFR)反式激活及增殖。
J Mol Neurosci. 2015 Jul;56(3):663-72. doi: 10.1007/s12031-015-0533-6. Epub 2015 Mar 12.
9
Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism.神经肽蛙皮素受体的激活通过 HER3 以 MAPK 依赖的机制刺激肺癌细胞的生长。
Biochim Biophys Acta Mol Cell Res. 2020 Apr;1867(4):118625. doi: 10.1016/j.bbamcr.2019.118625. Epub 2019 Dec 17.
10
Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells.垂体腺苷酸环化酶激活肽导致肺癌细胞中表皮生长因子受体的酪氨酸磷酸化。
J Pharmacol Exp Ther. 2012 Jun;341(3):873-81. doi: 10.1124/jpet.111.190033. Epub 2012 Mar 2.

引用本文的文献

1
Unlocking NAC's potential ATF4 and m6A dynamics in rescuing cognitive impairments in PTSD.释放N-乙酰半胱氨酸(NAC)在通过激活转录激活因子4(ATF4)和N6-甲基腺苷(m6A)动态变化来挽救创伤后应激障碍(PTSD)认知障碍方面的潜力。
Metab Brain Dis. 2025 Feb 15;40(2):129. doi: 10.1007/s11011-024-01485-7.
2
A Six-gene Prognostic Model Based on Neutrophil Extracellular Traps (NETs)-related Gene Signature for Lung Adenocarcinoma.基于中性粒细胞胞外诱捕网(NETs)相关基因特征的肺腺癌 6 基因预后模型。
Comb Chem High Throughput Screen. 2024;27(13):1969-1983. doi: 10.2174/0113862073282003240119064337.
3
Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer.癌症中的肽类G蛋白偶联受体与表皮生长因子受体酪氨酸激酶
Biology (Basel). 2023 Jul 4;12(7):957. doi: 10.3390/biology12070957.

本文引用的文献

1
Lung cancer.肺癌。
Lancet. 2021 Aug 7;398(10299):535-554. doi: 10.1016/S0140-6736(21)00312-3. Epub 2021 Jul 21.
2
Bombesin, endothelin, neurotensin and pituitary adenylate cyclase activating polypeptide cause tyrosine phosphorylation of receptor tyrosine kinases.蛙皮素、内皮素、神经降压素和垂体腺苷酸环化酶激活肽导致受体酪氨酸激酶的酪氨酸磷酸化。
Peptides. 2021 Mar;137:170480. doi: 10.1016/j.peptides.2020.170480. Epub 2020 Dec 29.
3
NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents.NRG1 融合驱动的肿瘤:生物学、检测以及阿法替尼和其他 ErbB 靶向药物的治疗作用。
Ann Oncol. 2020 Dec;31(12):1693-1703. doi: 10.1016/j.annonc.2020.08.2335. Epub 2020 Sep 9.
4
Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism.神经肽蛙皮素受体的激活通过 HER3 以 MAPK 依赖的机制刺激肺癌细胞的生长。
Biochim Biophys Acta Mol Cell Res. 2020 Apr;1867(4):118625. doi: 10.1016/j.bbamcr.2019.118625. Epub 2019 Dec 17.
5
Neurotensin receptors regulate transactivation of the EGFR and HER2 in a reactive oxygen species-dependent manner.神经降压素受体通过依赖活性氧的方式调节 EGFR 和 HER2 的转激活。
Eur J Pharmacol. 2019 Dec 15;865:172735. doi: 10.1016/j.ejphar.2019.172735. Epub 2019 Oct 12.
6
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.随机 II 期试验:西仑吉肽联合厄洛替尼治疗表皮生长因子受体野生型非小细胞肺癌患者。
Oncologist. 2019 Aug;24(8):1095-1102. doi: 10.1634/theoncologist.2018-0695. Epub 2019 Apr 11.
7
Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody.神经降压素抗体恢复顺铂敏感性对肺癌细胞可塑性和异质性的调控。
Cancer Lett. 2019 Mar 1;444:147-161. doi: 10.1016/j.canlet.2018.12.007. Epub 2018 Dec 21.
8
HER3 signaling and targeted therapy in cancer.癌症中的HER3信号传导与靶向治疗
Oncol Rev. 2018 May 16;12(1):355. doi: 10.4081/oncol.2018.355. eCollection 2018 Jan 30.
9
Neuropeptide G Protein-Coupled Receptors as Oncotargets.作为肿瘤靶点的神经肽G蛋白偶联受体
Front Endocrinol (Lausanne). 2018 Jun 29;9:345. doi: 10.3389/fendo.2018.00345. eCollection 2018.
10
A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.对heregulins、HER3和HER4作为癌症潜在治疗靶点的全面综述。
Oncotarget. 2017 Jun 13;8(51):89284-89306. doi: 10.18632/oncotarget.18467. eCollection 2017 Oct 24.